Long-Term Survival in Gastroesophageal Junction Adenocarcinoma: Ramucirumab

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
Long-Term Survival in Gastroesophageal Junction Adenocarcinoma: Ramucirumab ; volume:12 ; number:2 ; year:2018 ; pages:532-539
Case reports in gastroenterology ; 12, Heft 2 (2018), 532-539

Urheber
Gil-Delgado, Maria Angeles
Lucidarme, Olivier
Bachet, Jean Baptiste
Mahi, Naima
Khayat, David

DOI
10.1159/000490906
URN
urn:nbn:de:101:1-2018091300445493834093
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:36 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Gil-Delgado, Maria Angeles
  • Lucidarme, Olivier
  • Bachet, Jean Baptiste
  • Mahi, Naima
  • Khayat, David

Ähnliche Objekte (12)

Adenocarcinoma of the Gastroesophageal Junction Masquerading as Mallory-Weiss Syndrome

Adenocarcinoma of the Gastroesophageal Junction Masquerading as Mallory-Weiss Syndrome

Evolving Treatment Landscape for Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma

Evolving Treatment Landscape for Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma

Current molecular biomarkers evaluation in gastric/gastroesophageal junction adenocarcinoma: pathologist does matter

Current molecular biomarkers evaluation in gastric/gastroesophageal junction adenocarcinoma: pathologist does matter

Platelets as a prognostic factor for patients with adenocarcinoma of the gastroesophageal junction

Platelets as a prognostic factor for patients with adenocarcinoma of the gastroesophageal junction

HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives

HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives

Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma

Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma

Impact of Sites of Metastatic Dissemination on Survival in Advanced Gastroesophageal Adenocarcinoma

Impact of Sites of Metastatic Dissemination on Survival in Advanced Gastroesophageal Adenocarcinoma

A proactive financial navigation intervention in patients with newly diagnosed gastric and gastroesophageal junction adenocarcinoma

A proactive financial navigation intervention in patients with newly diagnosed gastric and gastroesophageal junction adenocarcinoma

Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial

Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial

Health-related quality of life after gastrectomy, esophagectomy, and combined esophagogastrectomy for gastroesophageal junction adenocarcinoma

Health-related quality of life after gastrectomy, esophagectomy, and combined esophagogastrectomy for gastroesophageal junction adenocarcinoma

Esophagectomy or Total Gastrectomy for Siewert 2 Gastroesophageal Junction (GEJ) Adenocarcinoma? A Registry-Based Analysis

Esophagectomy or Total Gastrectomy for Siewert 2 Gastroesophageal Junction (GEJ) Adenocarcinoma? A Registry-Based Analysis

Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction

Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction

Verbundene Objekte